Global Medical REIT Files 8-K

TL;DR

GMRE filed an 8-K, but no specifics yet.

AI Summary

Global Medical REIT Inc. filed an 8-K on April 5, 2024, reporting other events and financial statements. The filing does not contain specific details about the nature of these events or any financial figures.

Why It Matters

This filing indicates that Global Medical REIT Inc. has made a regulatory submission, but without further details, its immediate impact on investors is unclear.

Risk Assessment

Risk Level: low — The filing is a standard regulatory disclosure without immediate negative or positive financial implications.

Key Players & Entities

• Global Medical REIT Inc. (company) — Registrant
• April 5, 2024 (date) — Date of earliest event reported

FAQ

Key Financial Figures

• $0.001 — h registered: Common Stock, par value $0.001 per share GMRE NYSE Series A Pref

Filing Documents

• tm2411103d1_8k.htm (8-K) — 27KB
• tm2411103d1_ex5-1.htm (EX-5.1) — 29KB
• tm2411103_ex5-1img001.jpg (GRAPHIC) — 9KB
• tm2411103_ex5-1img002.jpg (GRAPHIC) — 6KB
• 0001104659-24-044305.txt ( ) — 297KB
• gmre-20240405.xsd (EX-101.SCH) — 3KB
• gmre-20240405_def.xml (EX-101.DEF) — 26KB
• gmre-20240405_lab.xml (EX-101.LAB) — 36KB
• gmre-20240405_pre.xml (EX-101.PRE) — 25KB
• tm2411103d1_8k_htm.xml (XML) — 5KB

01 Other Events

Item 8.01 Other Events. On April 5, 2024, Global Medical REIT Inc. (the "Company") filed a prospectus supplement (the "Prospectus Supplement") in connection with its "at the market offering" program (the "ATM Program") pursuant to the Company's registration statement on Form S-3ASR (File No. 333-276248), as amended by Post-Effective Amendment No. 1 ("Post-Effective Amendment No. 1") and Post-Effective Amendment No. 2 ("Post-Effective Amendment No. 2") thereto. The Company filed the Prospectus Supplement solely to move the ATM Program from Post-Effective Amendment No. 1 to Post-Effective Amendment No. 2, which Post-Effective Amendment No. 2 was filed because the Company no longer qualified as a "well-known seasoned issuer" (as such term is defined in Rule 405 of the Securities Act of 1933, as amended) when it filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2023. The opinion of Venable LLP, counsel to the Company, is filed as Exhibit 5.1 to this Report and is incorporated by reference to the Prospectus Supplement.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 5.1 Opinion of Venable LLP. 23.1 Consent of Venable LLP (included in Exhibit 5.1). 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Global Medical REIT Inc. By: /s/ Jamie A. Barber Jamie A. Barber Secretary and General Counsel Date: April 5, 2024

View Full Filing

View this 8-K filing on SEC EDGAR